Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
Penny Bemus, MBA, JD, Centric Health Resources
Advertisement
Articles by Penny Bemus, MBA, JD, Centric Health Resources
Advertisement
Latest Updated Articles
- Building an Alternative Distribution Model for Ultra-Orphan Diseases
Published: February 27th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound
2
Emotional Support as Strategy
3
Why DTC Drug Models Must Evolve From Access to True Patient Support
4
